RESUMEN
Pharmaceuticals constitute one of the most important emerging classes of environmental pollutants. A three-phase solvent system of water, water containing 0.1% of formic acid and acetonitrile was successfully used to separate, by liquid chromatography with mass spectrometry (LC-MS), polarity-matched pharmaceuticals, that is, carbamazepine, clarithromycin, and erythromycin, as well as amoxicillin and metformin. Despite of polarity similarities, these pharmaceuticals were completely resolved in the analytical run time of 15 min. The optimized three-phase solvent system based-method was validated for the simultaneous analysis of six matched-polarity pharmaceuticals in wastewater samples. Good linearity (coefficient of determination more than 0.993) and precision (relative standard deviation less than 15.66%) were achieved. Recovery of analytes from the wastewater was between 0.70 and 1.18. Limits of detections ranged from 0.0001 to 0.5114 µg/L. No significant matrix effect, evaluated by post extraction addition, was observed in the electrospray ionization (ESI) source. Then, this methodology has been successfully applied to environmental study of pharmaceutical residues occurring in influent and effluent wastewater samples, from the main wastewater treatment plant in Potenza (Basilicata, Southern Italy).
Asunto(s)
Amoxicilina/aislamiento & purificación , Carbamazepina/aislamiento & purificación , Claritromicina/aislamiento & purificación , Eritromicina/aislamiento & purificación , Metformina/aislamiento & purificación , Contaminantes Químicos del Agua/aislamiento & purificación , Amoxicilina/química , Carbamazepina/química , Cromatografía Liquida , Claritromicina/química , Eritromicina/química , Metformina/química , Tamaño de la Partícula , Solventes/química , Propiedades de Superficie , Espectrometría de Masas en Tándem , Aguas Residuales/química , Contaminantes Químicos del Agua/químicaRESUMEN
In this paper, the use of clarithromycin lactobionate, a kind of antibiotic chiral selector, in combination with four neutral cyclodextrin derivatives (glucose-ß-cyclodextrin, hydroxyethyl-ß-cyclodextrin, methyl-ß-cyclodextrin and hydroxypropyl-ß-cyclodextrin) was reported for the first time. As a result, these dual systems gave much better resolution of nefopam (the Rs increased to 3.58, 2.72, 1.49 and 1.42, respectively) compared to the single systems. The effects of buffer pH and selector concentration on the separation of nefopam were also investigated. Additionally, some other basic drugs including metoprolol, atenolol, propranolol, bisoprolol, esmolol and ritodrine were tested for the investigation and evaluation of the enantiorecognition capability of the four dual systems. As expected, the synergistic effect was observed in four systems. Different results of these dual systems were also summarized.
Asunto(s)
Antibacterianos/aislamiento & purificación , Claritromicina/aislamiento & purificación , Disacáridos/aislamiento & purificación , Electroforesis Capilar/métodos , Antibacterianos/química , Claritromicina/química , Disacáridos/química , EstereoisomerismoRESUMEN
A validated, reliable and accurate reversed-phase high performance liquid chromatographic method using pre-column derivatization was adopted for the simultaneous determination of two ternary mixtures containing omeprazole, tinidazole and doxycycline hyclate or clarithromycin. Separation was achieved on a C18 column, through a gradient elution system using acetonitrile-methanol-water adjusted to pH = 6.60. Drugs were detected at 277 nm over concentration ranges of 1-112, 5-125, 2.5-550 and 2.5-100 µg/mL for omeprazole, tinidazole, doxycycline hyclate and clarithromycin, respectively. This is the first method that has isolated and identified clarithromycin derivative by infrared and mass spectroscopy. This method is the first study for the simultaneous determination of omeprazole, tinidazole, doxycycline hyclate and clarithromycin in combined mixtures and pharmaceutical formulations.
Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Claritromicina/análisis , Doxiciclina/análisis , Omeprazol/análisis , Tinidazol/análisis , Cromatografía de Fase Inversa/métodos , Claritromicina/química , Claritromicina/aislamiento & purificación , Doxiciclina/química , Doxiciclina/aislamiento & purificación , Estabilidad de Medicamentos , Análisis de los Mínimos Cuadrados , Omeprazol/química , Omeprazol/aislamiento & purificación , Reproducibilidad de los Resultados , Comprimidos/química , Tinidazol/química , Tinidazol/aislamiento & purificaciónRESUMEN
OBJECTIVE: To make better the RP-HPLC method for the determination of roxithromycin(RM) in human serum. METHODS: RM and clarithromycin (internal standard) were extracted from alkalinized serum sample (500 microliters) with methylene chloride. After evaporation of the organic layer, the residue was dissolved in 100 microliters of acetonitrile-ammonium phosphate (1:1, pH 6.0) and washed with n-hexane, then 20 microliters was injected onto a column (5 microns, 15 cm x 4.6 mm) of Penomenex luna C18. The mobile phase was acetonitrile-0.05 mol/L phosphoric acid (39:19:42, adjusted to pH 7.2 with ammonia water) pumped at 1.2 ml/min through the column. The variable wavelength UV detector operated at 0.01 aufs and the wavelength was set at 210 nm. RESULTS: The retention times for RM and clarithromycin were 4.4 min and 5.0 min, respectively. Standard curve was linear in the concentration range of 0.25 to 32 mg/L. The detection limit in serum was 0.06 mg/L; the average method recovery 97.4%; the inter-day RSD less than 3.0%. CONCLUSION: This method was found to be simple, rapid, sensitive and accurate for determination of RM in human serum.